Lead Product(s): mRNA-1273
Therapeutic Area: Infections and Infectious Diseases Product Name: mRNA-1273
Highest Development Status: Phase III Product Type: Vaccine
Partner/Sponsor/Collaborator: Moderna Therapeutics
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement November 24, 2020
Recipharm has reserved capacity to support the anticipated demand for the vaccine (mRNA-1273) and is already in the process of recruiting additional staff and making certain investments to enable technology transfer and scale-up to commence imminently.